Facebook
Messenger
Twitter
LinkedIn
Email
Print
Mayo Researchers Explore Genetics Behind COVID-19 Outcomes
Share this:
Some patients with COVID-19 experience severe complications, such as organ damage, shortness of breath, neurological impairment and chronic fatigue. A team of researchers within Mayo Clinic Center for Individualized Medicine is contributing to the global effort of using advanced genetic sequencing to find out which genes influence disease outcomes.
“Our findings will be crucial in treating and caring for COVID-19 survivors, as well as to try to prevent lingering complications in newly infected people,” says Konstantinos Lazaridis, M.D., the Everett J. and Jane M. Hauck associate director of Mayo Clinic Center for Individualized Medicine.
Dr. Lazaridis and his team are building a library of genomic sequencing data of consented patients who tested positive for COVID-19. Learn more about Dr. Lazaridis' work at the Center for Individualized Medicine.
Make a gift now to help transform the future of health care today.
When Judy Alico passed away at age 51, her family was shell-shocked and heartbroken. Her husband, Bob, took action, forming a nonprofit to raise awareness and funding for Mayo Clinic and other organizations to study the condition that took Judy's life.
Judy Ethen lost her father and brother to pancreatic cancer. Her own case was diagnosed and treated early through Mayo Clinic’s High-Risk Pancreas Clinic, made possible by a generous gift of $22.1 million.
In an old family farmhouse outside small Delavan, Minnesota, Mike Hoffman is getting to know his mom a bit better. She died nearly 40 years ago, but through a stack of yellowed letters, Mike and his wife, Tami, are delving into a part of her life that they didn't previously know much about -- her life built upon her nursing studies at Mayo Clinic.